Статья

Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis

Juliana Barrera‐RamirezRegenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, ON, CanadaJessie R. LavoieCentre for Biologics Evaluation, Biologics Genetic and Therapies Directorate, Health Products Food Branch, Health Canada, Ottawa, ON, CanadaHarinad B. MagantiDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, CanadaWilliam L. StanfordDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, CanadaCaryn Y. ItoDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, CanadaMitchell SabloffHematology, Department of Medicine, The Ottawa Hospital and University of Ottawa, Ottawa, ON, CanadaMarjorie BrandDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, CanadaMichael Rosu‐MylesCentre for Biologics Evaluation, Biologics Genetic and Therapies Directorate, Health Products Food Branch, Health Canada, Ottawa, ON, CanadaYevgeniya LeRadiobiology and Health, Canadian Nuclear Laboratories, Chalk River, ON, CanadaDavid AllanDepartment of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada. [email protected]

2017en

ABI

Аннотация

Gene regulatory networks in AML may be influenced by microRNAs (miRs) contained in exosomes derived from bone marrow mesenchymal stromal cells (MSCs). We sequenced miRs from exosomes isolated from marrow-derived MSCs from patients with AML (n = 3) and from healthy controls (n = 3; not age-matched). Known targets of mIRs that were significantly different in AML-derived MSC exosomes compared to controls were identified. Of the five candidate miRs identified by differential packaging in exosomes, only miR-26a-5p and miR-101-3p were significantly increased in AML-derived samples while miR-23b-5p, miR-339-3p and miR-425-5p were significantly decreased. Validation of the predicted change in gene expression of the potential targets was investigated by interrogating gene expression levels from public datasets of marrow-derived CD34-selected cells from patients with AML (n = 69) and healthy donors (n = 40). Two molecules with decreased gene expression in AML (EZH2 and GSK3β) were predicted by the miR profiling and have been previously implicated in AML while three molecules were increased in AML-derived cells and have not been previously associated with leukemogenesis (KRBA2, RRBP1 and HIST2H 2BE). In summary, profiling miRs in exosomes from AML-derived MSCs allowed us to identify candidate miRs with potential relevance in AML that could yield new insights regarding leukemogenesis or new treatment strategies.

Перевод пока недоступен

Идентификаторы

DOI: 10.1007/s12015-017-9762-0

Цитирования и источники

Цитирований: 2Использованных источников: 0

Показатели — AkademScholar